Safety and Acceptability of Three Ablation Treatments for High-Grade Cervical Precancer: Early Data From a Randomized Noninferiority Clinical Trial The mean age of our patients was 63.7 years. All 18 ...

Vulvar cancer is a less common gynecological cancer. HPV infection, smoking, and having a precancerous condition called vulvar intraepithelial neoplasia all increase the risk. Outlook for vulvar ...

Precision medicine is looking increasingly promising in advanced vulvar squamous cell carcinomas (VSCCs), which make up 90% of vulvar cancers. The emergence of molecular stratification provides ...

Analysis of data from over 1.2 million US patients with gynecologic cancers between 2004 and 2020 revealed a significant shift towards surgical de-escalation, with increased use of minimally invasive ...

Vulvar cancer is typically slow-growing and may take several years to progress without treatment. However, some types can spread more rapidly. How fast vulvar cancer spreads depends on several factors ...

Although human papillomavirus (HPV) vaccines are best known for preventing cervical cancer, a new study from Sweden finds that women and girls who received the immunizations are also less likely to ...

PARPi-FL imaging of a clitoral excision – invasion from a vulvar squamous cell carcinoma. Imaging with PARPi-FL was also carried out in one patient harboring a recurrent squamous cell carcinoma of the ...

According to data from 2012–2018, those with vaginal cancer have a 51% likelihood of surviving for at least 5 years from the date of their diagnosis compared with people without the disease. This is ...